Ads

 

Ads

 

Ads

 

World Top 100 Pharmaceutical Companies List by Market Cap in January 2024

World Top 100 Pharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Pharmaceutical Companies in 2024
Metatag Abstract
World Top Pharmaceutical Companies by Market Cap in 2024, World Largest Pharmaceutical Companies by Market Cap in 2024.
  1. Caplin Point Laboratories

    World Rank (Jan-05-2024)
    7,323
    Market Cap (Jan-05-2024)
    1.320 Billion USD
    World Rank (Jul-30-2023)
    9,896
    Market Cap (Jul-30-2023)
    0.804 Billion USD
    World Rank (Dec-25-2022)
    10,820
    Market Cap (Dec-25-2022)
    0.647 Billion USD
    World Rank (Jan-07-2022)
    10,208
    Market Cap (Jan-07-2022)
    0.87 Billion USD
    Annual Revenue in USD
    158 Million USD
    Annual Net Income in USD
    38 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
  2. Elion Energy Company

    World Rank (Jan-05-2024)
    7,356
    Market Cap (Jan-05-2024)
    1.310 Billion USD
    World Rank (Jul-30-2023)
    6,379
    Market Cap (Jul-30-2023)
    1.684 Billion USD
    World Rank (Dec-25-2022)
    5,326
    Market Cap (Dec-25-2022)
    2.074 Billion USD
    World Rank (Jan-07-2022)
    4,689
    Market Cap (Jan-07-2022)
    3.14 Billion USD
    Headquarters Country
  3. Huapont Life Sciences

    World Rank (Jan-05-2024)
    7,367
    Market Cap (Jan-05-2024)
    1.307 Billion USD
    World Rank (Jul-30-2023)
    7,029
    Market Cap (Jul-30-2023)
    1.449 Billion USD
    World Rank (Dec-25-2022)
    6,728
    Market Cap (Dec-25-2022)
    1.437 Billion USD
    World Rank (Jan-07-2022)
    5,916
    Market Cap (Jan-07-2022)
    2.20 Billion USD
    Headquarters Country
  4. Renhe Pharmacy Co. Ltd

    World Rank (Jan-05-2024)
    7,371
    Market Cap (Jan-05-2024)
    1.306 Billion USD
    World Rank (Jul-30-2023)
    7,394
    Market Cap (Jul-30-2023)
    1.322 Billion USD
    World Rank (Dec-25-2022)
    7,062
    Market Cap (Dec-25-2022)
    1.337 Billion USD
    World Rank (Jan-07-2022)
    6,062
    Market Cap (Jan-07-2022)
    2.12 Billion USD
    Headquarters Country
  5. Sage Therapeutics

    World Rank (Jan-05-2024)
    7,382
    Market Cap (Jan-05-2024)
    1.301 Billion USD
    World Rank (Jul-30-2023)
    5,572
    Market Cap (Jul-30-2023)
    2.089 Billion USD
    World Rank (Dec-25-2022)
    4,977
    Market Cap (Dec-25-2022)
    2.288 Billion USD
    World Rank (Jan-07-2022)
    5,501
    Market Cap (Jan-07-2022)
    2.48 Billion USD
    Annual Revenue in USD
    8 Million USD
    Annual Operating Income in USD
    -546 Million USD
    Annual Net Income in USD
    -532 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Bio Pharmaceutical company with headquarters is in Massachusetts, USA.
  6. Deciphera Pharmaceuticals

    World Rank (Jan-05-2024)
    7,448
    Market Cap (Jan-05-2024)
    1.281 Billion USD
    World Rank (Jul-30-2023)
    8,471
    Market Cap (Jul-30-2023)
    1.056 Billion USD
    World Rank (Dec-25-2022)
    7,863
    Market Cap (Dec-25-2022)
    1.116 Billion USD
    World Rank (Jan-07-2022)
    13,040
    Market Cap (Jan-07-2022)
    0.53 Billion USD
    Annual Revenue in USD
    134 Million USD
    Annual Operating Income in USD
    -182 Million USD
    Annual Net Income in USD
    -178 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Deciphera Pharmaceuticals is a Healthcare company. The company developing novel drug candidates to improve the lives of cancer patients by addressing key mechanisms of tumor and drug resistance that limit the effectiveness of many cancer therapies. The headquarters is in USA.
  7. Karo Pharma AB (publ)

    World Rank (Jan-05-2024)
    7,487
    World Rank (Jul-30-2023)
    7,487
    World Rank (Dec-25-2022)
    7,487
    World Rank (Jan-07-2022)
    7,487
    Market Cap (Jan-07-2022)
    1.48 Billion USD
    Annual Revenue in USD
    279 Million USD
    Annual Net Income in USD
    -2 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Karo Pharma AB is a healthcare company own and commercialize branded, original over the counter products and prescription medicines. The company annual revenue is 2,882 million SEK, annual net income is 82 million SEK and total assets are 12.5 billion SEK as on 2020. The headquarters is in Sweden.
  8. Peptidream

    World Rank (Jan-05-2024)
    7,512
    Market Cap (Jan-05-2024)
    1.258 Billion USD
    World Rank (Jul-30-2023)
    6,400
    Market Cap (Jul-30-2023)
    1.676 Billion USD
    World Rank (Dec-25-2022)
    6,147
    Market Cap (Dec-25-2022)
    1.649 Billion USD
    World Rank (Jan-07-2022)
    5,361
    Market Cap (Jan-07-2022)
    2.59 Billion USD
    Annual Revenue in USD
    68 Million USD
    Annual Net Income in USD
    26 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    PeptiDream is a Biopharmaceutical company. It is the platform which enables the production of highly diverse non standard peptide libraries with high efficiency for the identification of highly potent and selective hit candidates which then can be developed into peptide based, small molecule based or peptide drug conjugate based therapeutics. The headquarters is in Japan.
  9. Chong Kun Dang Pharmaceutical

    World Rank (Jan-05-2024)
    7,532
    Market Cap (Jan-05-2024)
    1.252 Billion USD
    World Rank (Jul-30-2023)
    10,251
    Market Cap (Jul-30-2023)
    0.755 Billion USD
    World Rank (Dec-25-2022)
    9,552
    Market Cap (Dec-25-2022)
    0.806 Billion USD
    World Rank (Jan-07-2022)
    9,238
    Market Cap (Jan-07-2022)
    1.03 Billion USD
    Annual Revenue in USD
    1,005 Million USD
    Annual Net Income in USD
    32 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Chong Kun Dang Pharmaceutical is a Korean pharmaceutical company focused on the raw materials required for medicines from abroad. The company annual revenue is 1,343,559 million KRW and annual net income is 42,720 million KRW for year ending December 2021. The headquarters is in South Korea.

Share

Ads